Two groups of people were taken into consideration. One group had undergone metabolic surgery and a control group that hadn’t. People were matched by age, sex, location, educational levels, and other health conditions.
People who undergo metabolic surgery had a decreased risk of a “major adverse cardiovascular event” such as a stroke, heart attack or cardiac arrest, and they had a lower risk of dying for any reason. 3.2% of the group that had surgery experienced a major adverse cardiovascular event, compared to 4.5% of the control group.
Metabolic surgery should be considered as an effective option for treating patients with obesity and high blood pressure.